Skip to main content
SpringerLink
Log in

Bullöse Dermatosen

  • Chapter
Therapie der Hautkrankheiten

  • 229 Accesses

Zusammenfassung

Die Gruppe der Epidermolysis bullosa hereditaria (EBH) umfasst einige seltene Genodermatosen, deren gemeinsames Merkmal Blasenbildung im Bereich der Haut und der hautnahen Schleimhäute ist. Die Blasen können spontan auftreten oder werden durch Minimaltraumen induziert, offenbar bedingt durch Defekte diverser Proteine und Gene, die für die Verankerung zwischen Epidermis und Dermis verantwortlich sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 378.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Atherton DJ (1990) Therapy and counselling in epidermolysis bullosa. In: Wojnarowska F, Briggaman RA (eds) Management of blistering diseases. Chapman & Hall Medical, London, pp 173–187

    Google Scholar 

  • Bauer EA, Cooper TW, Tucker DR, Esterly NB (1980) Phenytoin therapy of recessive dystrophic epidermolysis bullosa: clinical trial and proposed mechanism of action on collagenase. N Engl J Med 303:776–781

    Article  PubMed  CAS  Google Scholar 

  • Bonnetblanc JM, Bouquier JJ (1986) Response to pipamper-one in a case of epidermolysis bullosa herpetiformis. Lancet I:1327–1328

    Article  Google Scholar 

  • Bruckner-Tuderman L (1995) Epidermolysis bullosa hereditaria. Hautarzt 46:61–72

    Article  PubMed  CAS  Google Scholar 

  • Bruckner-Tuderman L (1999) Hereditary skin diseases of anchoring fibrils. J Dermatol Sci 20:122–133

    Article  PubMed  CAS  Google Scholar 

  • Caldwell-Brown D, Stern RS, Lin AN, Carter DM (1992) Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. N Engl J Med 327:163–167

    Article  PubMed  CAS  Google Scholar 

  • Carter DM, Lin AN, Varghese MC et al. (1987) Treatment of junctional epidermolysis bullosa with epidermal autografts. J Am Acad Dermatol 17:246–250

    Article  PubMed  CAS  Google Scholar 

  • Cooper TW, Bauer EA (1984) Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis bullosa: a comparison of short- and long-term treatment. Arch Dermatol 120:490–495

    Article  PubMed  CAS  Google Scholar 

  • Engineer L, Ahmed AR (2001) Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 44: 818–828

    Article  PubMed  CAS  Google Scholar 

  • Fine JD, Eady RA, Bauer EA et al. (2000) Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 42:1051–1066

    Article  PubMed  CAS  Google Scholar 

  • Fine JD, Johnson LB, Wright JT (1991) Inherited blistering diseases of the skin. Pediatrician 18:175–187

    PubMed  CAS  Google Scholar 

  • Hill JC, Grimwood RE, Parsons DS (1992) Treatment of chronic erosions of junctional epidermolysis bullosa with human epidermal allografts. J Dermatol Surg Oncol 18:396–400

    Article  PubMed  CAS  Google Scholar 

  • Hintner H, Stingi G, Schuler P et al. (1981) Immunfluores-cence mapping of antigenic determinants within the dermal-epidermal junction in mechanobullous diseases. J Invest Dermatol 76:113–118

    Article  PubMed  CAS  Google Scholar 

  • McGrath JA, Schofield OM, Ishida-Yamamoto A et al. (1993) Cultured keratinocyte allografts and wound healing in severe recessive dystrophic epidermolysis bullosa. J Am Acad Dermatol 29: 407–419

    Article  PubMed  CAS  Google Scholar 

  • McGuire J, Birchall N, Cuono C et al. (1987) Successful engraftment of allogenic keratinocyte cultures in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 88:506

    Google Scholar 

  • Michaelson JD, Schmid JD, Dresden MH, Duncan C (1974) Vitamin treatment of epidermolysis bullosa: changes in tissue collagenase levels. Arch Dermatol 109: 67–69

    Article  PubMed  CAS  Google Scholar 

  • Rogers RB, Yancey KB, Aliens BS, Guil MF (1983) Phenytoin therapy for junctional epidermolysis bullosa. Arch Dermatol 119:925–927

    Article  PubMed  CAS  Google Scholar 

  • Spirito F, Meneguzzi G, Danos O et al. (2001) Cutaneous gene transfer and therapy: the present and the future. J Gene Med 3: 21–31

    Article  PubMed  CAS  Google Scholar 

  • Tadini G, Ermacora E, Cambiaghi S (1993) Positive response to 5HT-2 antagonists in a family affected by epidermolysis bullosa Dowling-Meara type. Dermatology 186: 80

    Article  PubMed  CAS  Google Scholar 

  • Travis SPL, McGrath JA, Turnbull AJ (1993) Oral and gastrointestinal manifestations of epidemolysis bullosa. Lancet 340:1505–1506

    Article  Google Scholar 

  • Wright JT, Fine JD, Johnson LB (1991) Oral soft tissues in hereditary epidermolysis bullosa. Oral Surg Oral Med Oral Pathol 71:440–446

    Article  PubMed  CAS  Google Scholar 

  • Collin P, Pukkala E, Reunala T (1996) Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 38:528–530

    Article  PubMed  CAS  Google Scholar 

  • Dieterich W, Laag E, Bruckner-Tudermann L et al. (1999) Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 113:133–136

    Article  PubMed  CAS  Google Scholar 

  • Fry L (1982) The treatment of dermatitis herpetiformis. Clin Exp Dermatol 7: 633–642

    Article  PubMed  CAS  Google Scholar 

  • Fry L, Leonard JN, Swain F et al. (1982) Long-term follow-up of dermatitis herpetiformis with and without dietary gluten withdrawal. Br J Dermatol 107: 631–640

    Article  PubMed  CAS  Google Scholar 

  • Hall RP (1992) Dermatitis herpetiformis. J Invest Dermatol 99:873–881

    Article  PubMed  Google Scholar 

  • Leonard JN, Tucker WFG, Fry JS et al. (1983) Increased incidence of malignancy in dermatitis herpetiformis. Br Med J 286:16–18

    Article  CAS  Google Scholar 

  • Lewis HM, Renauls TL, Garioch JJ et al. (1996) Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 135: 363–367

    Article  PubMed  CAS  Google Scholar 

  • Ljunghall K, Tjiernlund U (1983) Dermatitis herpetiformis: effect of gluten-restricted and gluten free diet on dap-sone requirement and on IgA and C3 deposits in unin-volved skin. Acta Derm Venereol (Stockh) 63:129–136

    CAS  Google Scholar 

  • Reunala T (1998) Dermatitis herpetiformis: coeliac disease of the skin. Ann Med 30: 416–418

    Article  PubMed  CAS  Google Scholar 

  • Reunala T, Mäki M (1993) Dermatitis herpetiformis: a genetic disease. Eur J Dermatol 3:519–526

    Google Scholar 

  • Shelley WB (1980) Treatment of dermatitis herpetiformis with cholestyramine. Br J Dermatol 103:663–666

    Article  PubMed  CAS  Google Scholar 

  • Silvers DN, Juhlin EA, Berczeller PH, McSorley J (1980) Treatment of dermatitis herpetiformis with colchicine. Arch Dermatol 116:1373–1374

    Article  PubMed  CAS  Google Scholar 

  • Stenveld HJ, Starink TM, Joost T van, Stoof TJ (1993) Efficacy of cyclosporine in two patients with dermatitis herpetiformis resistant to conventional therapy. J Am Acad Dermatol 28:1014–1015

    Article  PubMed  CAS  Google Scholar 

  • Zemtsov A, Neidner KH (1993) Successful treatment of dermatitis herpetiformis with tetracycline and nicotinamide in a patient unable to tolerate dapsone. J Am Acad Dermatol 28:505–506

    Article  PubMed  CAS  Google Scholar 

  • Chaffins ML, Collison D, Fivenson DP (1993) Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: A review of 13 cases. J Am Acad Dermatol 28:998–1000

    Article  PubMed  CAS  Google Scholar 

  • Chan LS, Cooper KD (1992) Interferon alpha for linear IgA bullous dermatosis. Lancet 340: 425

    Article  PubMed  CAS  Google Scholar 

  • Chorzelski T, Jablonska S (1988) Evolving concept of linear IgA dermatosis. Semin Dermatol 7: 225–232

    PubMed  CAS  Google Scholar 

  • Collier PM, Wojnarowska F (1993) Linear IgA disease and chronic bullous disease of childhood. Eur J Dermatol 3: 623–634

    Google Scholar 

  • Gosch S, Tronnier M, Wolff HH (1993) Die Therapie der IgA-linearen Dermatose im Kindesalter. Dermatol Monatsschr 179:330–333

    Google Scholar 

  • Kelly SE, Frith PA, Millard PR et al. (1988) A clinicopatho-logical study of mucosal involvement in linear IgA disease. Br J Dermatol 119:161–170

    Article  PubMed  CAS  Google Scholar 

  • Khan IU, Bhol KC, Ahmed AR (1999) Linear IgA bullous dermatosis in a patient with chronic renal failure: Response to intravenous immunoglobulin therapy. J Am Acad Dermatol 40:485–488

    Article  PubMed  CAS  Google Scholar 

  • Korman NJ (2000) New and emerging therapies in the treatment of blistering disease. Dermatol Clin 18:127–137

    Article  PubMed  CAS  Google Scholar 

  • Leonard JN, Haffenden GP, Ring NP et al. (1982) Linear IgA disease in adults. Br J Dermatol 107:301–316

    Article  PubMed  CAS  Google Scholar 

  • Mobacken H, Kastrup W, Ljunghall K et al. (1983) Linear IgA dermatosis: a study of ten adult patients. Acta Derm Venereol (Stockh) 63:123–128

    CAS  Google Scholar 

  • Nousari HC, Kimyai-Asadi A, Caeiro JP, Anhalt GJ (1999) Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Medicine 78:1–8

    Article  PubMed  CAS  Google Scholar 

  • Peoples D, Fivenson DP (1992) Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide. J Am Acad Dermatol 26:498–499

    Article  PubMed  CAS  Google Scholar 

  • Schiffner JH (1982) Therapy of childhood linear IgA dermatitis herpetiformis. J Am Acad Dermatol 6:403–404

    Article  PubMed  CAS  Google Scholar 

  • Wilson BD, Beutner EH, Kumar V et al. (1985) Linear bullous dermatosis. An immunologically defined disease. J Dermatol 24:596–574

    Google Scholar 

  • Wolfkamp L, Silleus-Smith JH (1991) Linear IgA dermatosis of childhood. Br J Dermatol 125:395–396

    Google Scholar 

  • Young HS, Coulson IH (2000) Linear IgA disease: successful treatment with cyclosporin. Br J Dermatol 143: 204–205

    Article  PubMed  CAS  Google Scholar 

  • Barthelemy H, Thivolet J, Cambazard F et al. (1986) Cyclosporin A in the treatment of bullous pemphigoid. Ann Dermatol Venereol 113:309–313

    PubMed  CAS  Google Scholar 

  • Beckers RC, Brand A, Vermeer BJ, Boom BW (1995) Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br J Dermatol 133:289–293

    Article  PubMed  CAS  Google Scholar 

  • Böhm M, Beissert S, Schwarz T, Metze D, Luger T (1997) Bullous pemphigoid treated with mycophenolate mofetil. Lancet 349:541

    Article  PubMed  Google Scholar 

  • Burton JL, Greaves MW (1974) Azathioprine for pemphigus and pemphigoid. Br J Dermatol 91:103–109

    Article  PubMed  CAS  Google Scholar 

  • Curley RK, Holden CA (1991) Steroid-resistent bullous pemphigoid treated with cyclosporin A. Clin Exp Dermatol 16: 68–69

    Article  PubMed  CAS  Google Scholar 

  • Fox BJ, Odom RB, Findlay RF (1982) Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol 7:504–510

    Article  PubMed  CAS  Google Scholar 

  • Grundmann-Kollmann M, Korting HC, Behrens S, Kaskel P, Leiter U, Krähn G, Kerscher M, Peter RU (1999) Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseases. J Am Acad Dermatol 40:957–960

    Article  PubMed  CAS  Google Scholar 

  • Guillaume JC, Vaillant L, Bernard P et al. (1993) Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol 129: 49–53

    Article  PubMed  CAS  Google Scholar 

  • Heilborn JD, Ståhle-Bäckdahl M, Albertioni F, Vassilaki I, Peterson C, Stephansson E (1999) Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid. J Am Acad Dermatol 40:741–749

    Article  PubMed  CAS  Google Scholar 

  • Hornschuh B, Hamm H, Wever S, Hashimoto T, Schröder U, Bröcker EB, Zillikens D (1997) Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. J Am Acad Dermatol 36:101–103

    Article  PubMed  CAS  Google Scholar 

  • Huilgol SC, Black MM (1995) Management of the immunobullous disorders. I. Pemphigoid. Clin Exp Dermatol 20: 189–201

    Article  PubMed  CAS  Google Scholar 

  • Korman N (1987) Bullous pemphigoid. J Am Acad Dermatol 16:907–924

    Article  PubMed  CAS  Google Scholar 

  • Nemeth AJ, Klein AD, Gold EW et al. (1991) Bullous pemphigoid in children 127:378–386

    CAS  Google Scholar 

  • Nousari HC, Anhalt GJ (1999) Pemphigus and bullous pemphigoid. Lancet 354: 667–672

    Article  PubMed  CAS  Google Scholar 

  • Nousari HC, Griffin WA, Anhalt GJ (1998) Successful therapy for bullous pemphigoid with mycophenolate mofetil. J Am Acad Dermatol 39:497–498

    Article  PubMed  CAS  Google Scholar 

  • Roujeau JC, Lok C, Bastuji-Garin S, Mhalla S, Enginger V, Bernard P (1998) High risk of death in elderly patients with extensive bullous pemphigoid. Arch Dermatol 134:465–469

    Article  PubMed  CAS  Google Scholar 

  • Ruocco V, Sacerdoti G (1991) Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 30:307–312

    Article  PubMed  CAS  Google Scholar 

  • Siegel J, Eaglstein WH (1984) High-dose methylprednisolone in the treatment of bullous pemphigoid. Arch Dermatol 120:1157–1165

    Article  PubMed  CAS  Google Scholar 

  • Stabley JR, Hawley-Nelson P, Yuga SH et al. (1981) Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamosus epithelia. Cell 24: 897–903

    Article  Google Scholar 

  • Thivolet J, Barthelemy H, Rigot-Muller G, Bendelac A (1985) Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet 1:334–335

    Article  PubMed  CAS  Google Scholar 

  • Thomas I, Khorenian S, Arbesfeld DM (1993) Treatment of generalized bullous pemphigoid with oral teracycline. J Am Acad Dermatol 28: 74–77

    Article  PubMed  CAS  Google Scholar 

  • Ueda Y, Nashiro K, Seki Y et al. (1989) Pemphigoid vegetans. Br J Dermatol 120:449–453

    Article  PubMed  CAS  Google Scholar 

  • Venning VA, Millard PR, Wojnarowska F (1989) Dapsone as first line therapy for bullous pemphigoid. Br J Dermatol 120:83–92

    Article  PubMed  CAS  Google Scholar 

  • Venning VA, Wojnarowska F (1992) Lack of predictive factors for the clinical course of bullous pemphigoid. J Am Acad Dermatol 26:585–589

    Article  PubMed  CAS  Google Scholar 

  • Wollina U, Lange D, Looks A (1999) Short-time extracorporeal photochemotherapy in the treatment of drug-resistant autoimmune bullous diseases. Dermatology 198: 140–144

    Article  PubMed  CAS  Google Scholar 

  • Ahmed AR, Kurgis BS, Rogers RS (1991) Cicatricial pemphigoid. J Am Acad Dermatol 24:987–1001

    Article  PubMed  CAS  Google Scholar 

  • Anhalt GJ, Morrison LH (1991) Bullous and cicatrial pemphigoid. J Autoimmun 4:17–35

    Article  PubMed  CAS  Google Scholar 

  • van der Wal V, Jonkman F (1997) Topical tetracycline in cicatricial pemphigoid. J Am Acad Dermatol 36: 492–493

    Article  Google Scholar 

  • Eisen D, Ellis CN, Voorhees JJ (1990) Topical cyclosporine for oral bullous disorders. J Am Acad Dermatol 23: 936–937

    Article  PubMed  CAS  Google Scholar 

  • Elder MJ, Leonard J, Dart JKG (1996) Sulphapyridine — a new agent for the treatment of ocular cicatricial pemphigoid. Br J Ophthalmol 80:549–552

    Article  PubMed  CAS  Google Scholar 

  • Fern AI, Jay JL, Young H, MacKie R (1992) Dapsone therapy for the acute inflammatory phase of ocular pemphigoid. Br J Ophthalmol 76:332–335

    Article  PubMed  CAS  Google Scholar 

  • Fleming TE, Korman NJ (2000) Cicatricial pemphigoid. J Am Acad Dermatol 43:571–591

    Article  PubMed  CAS  Google Scholar 

  • Foster CS (1986) Cicatricial pemphigoid. Trans Am Ophthalmol Soc 84:527–663

    PubMed  CAS  Google Scholar 

  • Gillies M, Francis I, McCluskey P, Wakefield D (1996) Local interferon alfa-2b for ocular cicatricial pemphigoid. Br J Ophthalmol 80: 927–933

    Article  PubMed  CAS  Google Scholar 

  • McFadden JP, Leonard JN, Powles AV et al. (1989) Sulphamethoxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 121:759–762

    Article  PubMed  CAS  Google Scholar 

  • Mondino BJ, Brown SI (1983) Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 96:453–459

    PubMed  CAS  Google Scholar 

  • Poskitt L, Wojnarowska F (1995) Minimizing cicatricial pemphigoid orodynia with minocycline. Br J Dermatol 132:784–789

    Article  PubMed  CAS  Google Scholar 

  • Rogers RS, Seehafer JR, Perry HO (1982) Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 6: 215–223

    Article  PubMed  Google Scholar 

  • Shore JW, Foster CS, Westfall CT, Rubin PAD (1992) Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 99:383–395

    PubMed  CAS  Google Scholar 

  • Tauber J, Sainz de la Maza M, Foster CS (1991) Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 10:185–195

    Article  PubMed  CAS  Google Scholar 

  • Aberer W, Wolff-Schreiner EC, Stingi G, Wolff K (1987) Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up. J Am Acad Dermatol 16:527–533

    Article  PubMed  CAS  Google Scholar 

  • Ahmed AR, Moy R (1982) Death in pemphigus. J Am Acad Dermatol 7:221–228

    Article  PubMed  CAS  Google Scholar 

  • Ahmed AR, Hombal S (1987) Use of cyclophosphamide in azathioprine failures in pemphigus. J Am Acad Dermatol 17:437–42

    Article  PubMed  CAS  Google Scholar 

  • Appelhans M, Bonsmann G, Oerge C, Bröcker E-B (1993) Dexamethason-Cyclophosphamid-Stoßtherapie bei blasenbildenden Autoimmundermatosen. Hautarzt 44:143–147

    PubMed  CAS  Google Scholar 

  • Barthelemy H, Frappaz A, Cambazard F et al. (1988) Treatment of nine patients with pemphigus vulgaris with cyclosporine. J Am Acad Dermatol 18:1262–1266

    Article  PubMed  CAS  Google Scholar 

  • Beckers RC, Brand A, Vermeer BJ, Boom BW (1995) Adjuvant high-dose intravenous gammaglobulin in the treatment of pemphigus and bullous pemphigoid: experience in six patients. Br J Dermatol 133: 289–293

    Article  PubMed  CAS  Google Scholar 

  • Burton JL, Greaves MW (1974) Azathioprine for pemphigus and pemphigoid. Br J Dermatol 91:103–109

    Article  PubMed  CAS  Google Scholar 

  • Bystryn JC, Steinman NM (1996) The adjuvant therapy of pemphigus. Arch Dermatol 132:203–212

    Article  PubMed  CAS  Google Scholar 

  • Carson PJ, Hameed A, Ahmed AR (1996) Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol 34: 645–652

    Article  PubMed  CAS  Google Scholar 

  • Chaffins ML, Collison D, Fivenson DP (1993) Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases. J Am Acad Dermatol 28:998–1000

    Article  PubMed  CAS  Google Scholar 

  • Enk AH, Knop J (1997) Treatment of pemphigus vulgaris with mycophenolate mofetil. Lancet 350:494

    Article  PubMed  CAS  Google Scholar 

  • Enk AH, Knop J (1998) Adjuvante Therapie von Pemphigus vulgaris und Pemphigus foliaceus mit intravenösen Immunglobulinen. Hautarzt 49:774–776

    Article  PubMed  CAS  Google Scholar 

  • Euler HH, Löffler H, Christophers E (1987) Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol 123:1205–1210

    Article  PubMed  CAS  Google Scholar 

  • Fellner MJ, Katz JM, McCabe JB (1978) Successful use of cyclophosphamide and prednisone for the initial treatment of pemphigus vulgaris. Arch Dermatol 114:889–894

    Article  PubMed  CAS  Google Scholar 

  • Fleischli ME, Valek RH, Pandya AG (1999) Pulse intravenous cyclophosphamide therapy in pemphigus Arch Dermatol 135:57–61

    Article  PubMed  CAS  Google Scholar 

  • Gollnick HPM, Owsianowski M, Taube KM, Orfanos CE (1993) Unresponsive severe generalized pemphigus vulgaris successfully controlled by extracorporeal photopheresis. J Am Acad Dermatol 28:122–124

    Article  PubMed  CAS  Google Scholar 

  • Guillaume JC, Roujeau JC, Morel P et al. (1988) Controlled study of plasma exchange in pemphigus. Arch Dermatol 124:1659–1663

    Article  PubMed  CAS  Google Scholar 

  • Hahn K, Kippes W, Amagai M et al. (2000) Klinik und Immunpathologie bei 48 Patienten mit Pemphigus. Hautarzt 51: 670–677

    Article  PubMed  CAS  Google Scholar 

  • Hodak E, Lapidoth M, David M (1999) Effect of colchicine in the subcorneal pustular dermatosis type of IgA pemphigus. J Am Acad Dermatol 40: 91–94

    Article  PubMed  CAS  Google Scholar 

  • Huilgol SC, Black MM (1995) Management of the immunobullous disorders. II. Pemphigus. Clin Exp Dermatol 20: 283–293

    Article  PubMed  CAS  Google Scholar 

  • Jolies S, Hughes J, Rustin M (1999) Therapeutic failure of high-dose intravenous immunoglobulin in pemphigus vulgaris J Am Acad Dermatol 40: 499–500

    Article  Google Scholar 

  • Lapidoth M, David M, Ben-Amitai D et al. (1994) The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. J Am Acad Dermatol 30:752–757

    Article  PubMed  CAS  Google Scholar 

  • Lever WF (1972) Methotrexate and prednisone in pemphigus vulgaris: therapeutic results obtained in 36 patients between 1961–1970. Arch Dermatol 106:491–497

    Article  PubMed  CAS  Google Scholar 

  • Lever WF, Schaumburg-Lever G (1984) Treatment of pemphigus vulgaris. Arch Dermatol 120:44–47

    Article  PubMed  CAS  Google Scholar 

  • Lu SY, Chen WJ, Eng HL, Hsien K (1998) Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:438–445

    Article  PubMed  CAS  Google Scholar 

  • Mashkilleyson N, Mashkilleyson AL (1988) Mucous membrane manifestations of pemphigus vulgaris: a 25-year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin. Acta Derm Venereol (Stockh) 68:413–421

    CAS  Google Scholar 

  • Mobini N, Padilla T, Ahmed AR (1997) Long-term remission in selected patients with pemphigus vulgaris treated with cyclosporine. J Am Acad Dermatol 36:264–266

    Article  PubMed  CAS  Google Scholar 

  • Mourellou O, Chaidemenos GC, Koussidou TH, Kapetis E (1995) The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period. Br J Dermatol 133: 83–87

    Article  PubMed  CAS  Google Scholar 

  • Pandya AG, Dyke C (1998) Treatment of pemphigus with gold. Arch Dermatol 134:1104–1107

    Article  PubMed  CAS  Google Scholar 

  • Pandya AG, Sontheimer RD (1992) Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide. Arch Dermatol 128:1626–1630

    Article  PubMed  CAS  Google Scholar 

  • Pasricha JS, Sood VD, Minocha Y (1975) Treatment of pemphigus with cyclophosphamide. Br J Dermatol 93:573–576

    Article  PubMed  CAS  Google Scholar 

  • Pasricha JS, Khaitan BK, Raman RS, Chandra M (1995) Dexamethasone-cyclophosphamide pulse therapy for pemphigus. Int J Dermatol 34: 875–882

    Article  PubMed  CAS  Google Scholar 

  • Penneys NS, Eaglstein WH, Frost P (1976) Management of pemphigus with gold compounds. Arch Dermatol 112: 185–187

    Article  PubMed  CAS  Google Scholar 

  • Poulin Y, Perry HO, Muller SA (1985) Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients. J Am Acad Dermatol 11:851–857

    Article  Google Scholar 

  • Ratnam KV, Phay KL, Tan CK (1990) Pemphigus therapy with oral prednisolone regimens: a 5-year study. Int J Dermatol 29:363–367

    Article  PubMed  CAS  Google Scholar 

  • Rook AH, Jegasothy BV, Heald P et al. (1990) Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med 112:303–305

    Article  PubMed  CAS  Google Scholar 

  • Roujeau JC, Andre C, Fabre MJ et al. (1983) Plasma exchange in pemphigus. Arch Dermatol 119: 215–221

    Article  PubMed  CAS  Google Scholar 

  • Scully C, Almeida OP de, Porter SR, Gilkes JJH (1999) Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol 140:84–89

    Article  PubMed  CAS  Google Scholar 

  • Siegel J, Eaglstein WH (1984) High-dose methylprednisolone in the treatment of bullous pemphigoid. Arch Dermatol 120:1157–1165

    Article  PubMed  CAS  Google Scholar 

  • Smolle J (1985) Zur Therapie der Pemphiguskrankheiten. Hautarzt 36:96–102

    PubMed  CAS  Google Scholar 

  • Takamori K, Yamada H, Morioka S, Ogawa H (1993) Long-term remission successfully achieved in severe types of pemphigus vulgaris and bullous pemphigoid by the use of plasmapheresis. Eur J Dermatol 3:433–437

    Google Scholar 

  • Tan-Lim R, Bystryn JC (1990) Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. J Am Acad Dermatol 22:35–40

    Article  PubMed  CAS  Google Scholar 

  • Thivolet J, Barthelemy H, Rigit-Muller G, Bendeloc A (1985) Effects of cyclosporin on bullous pemphigoid and pemphigus. Lancet I:334–335

    Article  Google Scholar 

  • Wallach D (1992) Intraepidermal IgA pustulosis. J Am Acad Dermatol 27:993–1000

    Article  PubMed  CAS  Google Scholar 

  • William DM (1989) Vesiculobullous mucocutaneous disease: pemphigus vulgaris. J Oral Pathol Med 18:544–553

    Article  Google Scholar 

  • Amerian ML, Ahmed AR (1985) Pemphigus foliaceus: Senear-Usher syndrome. Int J Dermatol 24:16–25

    Article  PubMed  CAS  Google Scholar 

  • Azaria JM, Misa RF de, Harto A, Ledo A (1997) Severe pemphigus foliaceus treated with extracorporeal photochemotherapy. Arch Dermatol 133:287–289

    Article  Google Scholar 

  • Balda BR, Rosenzweig D (1986) Cyclosporin A in der Behandlung von Pemphigus foliaceus und Pemphigus erythematosus. Hautarzt 37: 454–457

    PubMed  CAS  Google Scholar 

  • Bassett N, Guillot B, Michel B et al. (1987) Dapsone as initial treatment in superficial pemphigus. Arch Dermatol 123:783–785

    Article  Google Scholar 

  • Cintin C, Joffe P (1992) Pemphigus foliaceus treated successfully with plasma exchange. Int J Dermatol 31: 871–872

    Article  PubMed  CAS  Google Scholar 

  • Hymes SR, Jordon RE (1992) Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy. Arch Dermatol 128:1462–1464

    Article  PubMed  CAS  Google Scholar 

  • Roujeau J, Andre C, Fabre JM et al. (1983) Plasma exchange in pemphigus. Arch Dermatol 119: 215–221

    Article  PubMed  CAS  Google Scholar 

  • Diaz LA, Sampaio SA, Rivitti EA et al. (1989) Endemic pemphigus foliaceus (fogo seivagem): I. Clinical features and immunopathology. J Am Acad Dermatol 20: 657–669

    Article  PubMed  CAS  Google Scholar 

  • Diaz LA, Sampaio SA, Rivitti EA et al. (1989) Endemic pemphigus foliaceus (fogo sevalgem): II. Current and historic epidemiologic studies. J Invest Dermatol 92:4–12

    Article  PubMed  CAS  Google Scholar 

  • Hans-Filho G, Aoki V, Rivitti E, Eaton DP, Lin MS, Diaz LA (1999) Endemic pemphigus foliaceus (fogo seivagem). Clin Dermatol 17:225–235

    Article  PubMed  CAS  Google Scholar 

  • Kunte Ch, Barbosa JM, Wolff H, Meurer M (1997) Brasilianischer Pemphigus foliaceus (Fogo seivagem) Hautarzt 48:228–233

    Article  PubMed  CAS  Google Scholar 

  • Lombardi C, Borges PC, Chaul A et al. (1992) Environmental risk factors in endemic pemphigus foliaceus (fogo seivagem). J Invest Dermatol 98:847–850

    Article  PubMed  CAS  Google Scholar 

  • Roscoe JT, Naylor PH, Diaz LA et al. (1986) Elevated thymosin alpha 1 levels in Brasilian pemphigus foliaceus. Br J Dermatol 115:147–150

    Article  PubMed  CAS  Google Scholar 

  • Anhalt GJ (1989) Drug-induced pemphigus. Semin Dermatol 8:166–172

    PubMed  CAS  Google Scholar 

  • Brenner S, Bialy-Golan A, Ruocco V (1998) Drug-induced pemphigus. Clin Dermatol 16:393–397

    Article  PubMed  CAS  Google Scholar 

  • Civatte J (1989) Durch Medikamente induzierte Pemphiguserkrankungen. Dermatol Monatsschr 175:1–7

    PubMed  CAS  Google Scholar 

  • Kaplan RP, Potter TS, Fox JN (1992) Drug-induced pemphigus related to angiotensin-converting enzyme inhibitors. J Am Acad Dermatol 26:364–366

    Article  PubMed  CAS  Google Scholar 

  • Ruocco V, Pisani M (1982) Induced Pemphigus. Arch Dermatol Res 274:123–140

    Article  PubMed  CAS  Google Scholar 

  • Ruocco VR, Sacerdoti G (1991) Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol 30:307–312

    Article  PubMed  CAS  Google Scholar 

  • Shelton RM (1991) Pemphigus foliaceus associated with enalapril. J Am Acad Dermatol 24:503–504

    Article  PubMed  CAS  Google Scholar 

  • Verdier-Sevrain S, Joly P, Thomine E et al. (1994) Thiopronine-induced herpetiform pemphigus: report of a case studied by immunoelectronmicroscopy and immunoblot analysis. Br J Dermatol 130: 238–240

    Article  PubMed  CAS  Google Scholar 

  • Wolf R, Tamir A, Brenner S (1991) Drug-induced versus drug-triggered pemphigus. Dermatologica 182:207–210

    Article  PubMed  CAS  Google Scholar 

  • Anhalt GJ, Kim SC, Stanley JR et al. (1990) Paraneoplastic pemphigus. N Engl J Med 323:1729–1735

    Article  PubMed  CAS  Google Scholar 

  • Camisa C, Helm TN, Liu YC et al. (1992) Paraneoplastic pemphigus: a report of three cases including one long-term survivor. J Am Acad Dermatol 27:547–553

    Article  PubMed  CAS  Google Scholar 

  • Fullerton SH, Woodley DT, Smoller BR et al. (1992) Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA 267:1500–1502

    Article  PubMed  CAS  Google Scholar 

  • Horn TD, Anhalt GJ (1992) Histologic features of paraneoplastic pemphigus. Arch Dermatol 128:1091–1095

    Article  PubMed  CAS  Google Scholar 

  • Oursler JR, Labib RS, Ariss-Abdo L et al. (1992) Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 323:1775–1782

    Article  Google Scholar 

  • Robinson ND, Hashimoto T, Amagai M, Chan LS (1999) The new pemphigus variants. J Am Acad Dermatol 40:649–671

    Article  PubMed  CAS  Google Scholar 

  • Younis J, Ahmed AR (1990) The relationship of pemphigus to neoplasia. J Am Acad Dermatol 23:498–502

    Article  Google Scholar 

  • Bauwens M, Ce Coninck A, Roseeuw D (1999) Subcorneal pustular dermatosis treated with PUVA therapy. A case report and review of the literature. Dermatology 198:203–205

    Article  PubMed  CAS  Google Scholar 

  • Iandoli R, Monfrecola G (1987) Treatment of subcorneal pustulosis with etretinate. Dermatologica 175: 235–238

    Article  PubMed  CAS  Google Scholar 

  • Lutz ME, Daoud MS, McEvoy MT, Gibson LE (1998) Subcorneal pustular dermatosis: a clinical study of ten patients. Cutis 61: 203–208

    PubMed  CAS  Google Scholar 

  • Orton DI, George SA (1997) Subcorneal pustular dermatosis responsive to narrowband (TL-01) UVB phototherapy. Br J Dermatol 137:149–150

    Article  PubMed  CAS  Google Scholar 

  • Sneddon JB, Wilkinson DS (1979) Subcorneal pustular dermatosis. Br J Dermatol 100: 61–68

    Article  PubMed  CAS  Google Scholar 

  • Todd DJ, Bingham EA, Walsh M, Burrows D (1991) Subcorneal pustular dermatosis and IgA paraproteinaemia: response to both etretinate and PUVA. Br J Dermatol 125: 387–389

    Article  PubMed  CAS  Google Scholar 

  • Aoki T, Hashimoto H, Koseki S, Hozumi Y, Kondo S (1998) 1alpha, 24-dihydroxyvitamin D3 (tacalcitol) is effective against Hailey-Hailey disease both in vivo and in vitro. Br J Dermatol 139: 897–901

    Article  PubMed  CAS  Google Scholar 

  • Ayres S Jr (1983) Hailey-Hailey disease: response to vitamin E therapy Arch Dermatol 119:450

    Article  PubMed  Google Scholar 

  • Beier C, Kaufmann R (1999) Efficacy of erbium: YAG laser ablation in Darier disease and Hailey-Hailey disease. Arch Dermatol 135:423–427

    Article  PubMed  CAS  Google Scholar 

  • Burge SM (1992) Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 126: 275–282

    Article  PubMed  CAS  Google Scholar 

  • Don PC, Carney PS, Lynch WS et al. (1987) Carbon dioxide laser abrasion: a new approach to management of familial benign chronic pemphigus (Hailey-Hailey disease). J Dermatol Surg Oncol 13:1187–1194

    Article  PubMed  CAS  Google Scholar 

  • Fairris GM, White JE, Leppard BJ, Goodwin PG (1986) Methotrexate for intractable benign familial chronic pemphigus. Br J Dermatol 115: 640

    Article  PubMed  CAS  Google Scholar 

  • Galimberti RL, Kowalczuk AM, Bianchi O et al. (1988) Chronic benign familial pemphigus. Int J Dermatol 27:495–500

    Article  PubMed  CAS  Google Scholar 

  • Hums R (1984) PUVA-Therapie bei Pemphigus chronicus benignus familiaris. Dermatol Monatsschr 170:715–718

    PubMed  CAS  Google Scholar 

  • Ikeda S, Suga Y, Ogawa H (1993) Successful management of Hailey-Hailey disease with potent topical steroid ointment. J Dermatol Sci 5: 205–211

    Article  PubMed  CAS  Google Scholar 

  • Kartamaa M, Reitamo S (1992) Familial benign chronic pemphigus (Hailey-Hailey disease). Treatment with carbon dioxide laser vaporization. Arch Dermatol 128: 646–648

    Article  PubMed  CAS  Google Scholar 

  • Kauten JR, Zook EG, Kumar AA, Kinkead LR (1982) Surgical management of familial benign chronic pemphigus by excision and primary closure. Ann Plast Surg 9:337–343

    Article  PubMed  CAS  Google Scholar 

  • Kirtschig G, Gieler U, Happle R (1993) Treatment of Hailey-Hailey disease by dermabrasion. J Am Acad Dermatol 28: 784–786

    Article  PubMed  CAS  Google Scholar 

  • McElroy JA, Mehregan DA, Roenigk RK (1990) Carbon dioxide laser vaporization of recalcitrant symptomatic plaques of Hailey-Hailey disease and Darier’s disease. J Am Acad Dermatol 23: 893–897

    Article  PubMed  CAS  Google Scholar 

  • Ormerod AD, Duncan J, Stankler L (1991) Benign familial pemphigus responsive to cyclosporin, a possible role for cellular immunity in pathogenesis. Br J Dermatol 124: 299–305

    Article  PubMed  CAS  Google Scholar 

  • Peled I, Weinrauch L, Kaplan H, Wexler MR (1980) Surgical management of Hailey-Hailey disease: report of a case. J Dermatol Surg Oncol 6:662–663

    PubMed  CAS  Google Scholar 

  • Quitadamo MJ, Spencer SK (1991) Surgical management of Hailey-Hailey disease (letter). J Am Acad Dermatol 25:342–343

    Article  PubMed  CAS  Google Scholar 

  • Schnitzler L (1984) Effect bénéfique de la thalidomide dans un cas de pemphigus de Hailey-Hailey (letter). Ann Dermatol Venereol 111:285–286

    PubMed  CAS  Google Scholar 

  • Sire DJ, Johnson BL (1971) Benign familial chronic pemphigus treated with dapsone. Arch Dermatol 103:262–265

    Article  PubMed  CAS  Google Scholar 

  • Crow LL, Finkle JP, Gammon WR, Woodley DT (1988) Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 19:937–942

    Article  PubMed  CAS  Google Scholar 

  • Cunningham BB, Kirchmann TTT, Woodley D (1996) Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 34:781–784

    Article  PubMed  CAS  Google Scholar 

  • Engineer L, Ahmed AR (2001) Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 44: 818–828

    Article  PubMed  CAS  Google Scholar 

  • Gammon WR, Briggaman RA, Inman AO et al. (1984) Differentiating anti-lamina lucida and sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 82:139–144

    Article  PubMed  CAS  Google Scholar 

  • Gammon WR (1991) Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen. J Autoimmun 4:59–71

    Article  PubMed  CAS  Google Scholar 

  • Gordon KB, Chan LS, Woodley DT (1996) Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photo chemotherapy. Br J Dermatol 136: 415–420

    Article  Google Scholar 

  • Meier F, Sönnichsen K, Schaumburg-Lever G et al. (1993) Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 29:334–337

    Article  PubMed  CAS  Google Scholar 

  • Merle C, Blanc D, Zultak M et al. (1990) Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin. Dermatologica 181:44–47

    Article  PubMed  CAS  Google Scholar 

  • Michalaki H, Staquet MJ, Cerri A et al. (1990) Expression of the α6/β4 integrin in lesionai skin differentiates bullous pemphigoid (BP) from epidermolysis bullosa acquisita (EBA). J Invest Dermatol 98: 204–208

    Article  Google Scholar 

  • Nieboer C, Boorsma DM, Woerdeman MJ et al. (1980) Epidermolysis bullosa acquisita. Br J Dermatol 102:383–392

    Article  PubMed  CAS  Google Scholar 

  • Robinowitz BN, Towery DS, Meyers SW, Durick WJ, Taira JW (1997) Successful treatment of epidermolysis bullosa acquisita with mesalazine. Br J Dermatol 137:154

    Article  PubMed  CAS  Google Scholar 

  • Woodley DT, Brigggaman RA, Gammon WR (1988) Review and update of epidermolysis bullosa acquisita. Semin Dermatol 7:111–122

    PubMed  CAS  Google Scholar 

  • Yaoita H, Briggaman RA, Lawley TJ et al. (1981) Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 76: 288–292

    Article  PubMed  CAS  Google Scholar 

  • Zachariae H (1987) Cyclosporine A in epidermolysis bullosa acquisita. J Am Acad Dermatol 17:1058–1059

    Article  PubMed  CAS  Google Scholar 

  • Rhodes LE, Tingle MD, Park BK, Chu P, Verbov JL, Friedmann PS (1995) Cimetidine improves the therapeutic/ toxic ratio of dapsone in patients on chronic dapsone therapy. Br J Dermatol 132:257–262

    Article  PubMed  CAS  Google Scholar 

  • Wozel G (1993) Dapson — Pharmakologie, Wirkungsmechanismus und klinischer Einsatz in der Dermatologie. Dermatol Monatsschr 179:1–9

    Google Scholar 

  • Eastell R, Reid DM, Compston J et al. (1998) A UK consensus group on management of glucocorticoidinduced osteoporosis: an update. J Intern Med 244: 271–292

    Article  PubMed  CAS  Google Scholar 

  • Schmidt E, Zillikens D (2000) Autoimmune and inherited subepidermal blisering disease: advances in the clinic and the laboratory. Adv Dermatol 16:113–157

    PubMed  CAS  Google Scholar 

  • Williams LC, Nesbitt LT (2001) Update on systemic glucocorticosteroids in dermatology. Dermatol Clin 19: 63–77

    Article  PubMed  CAS  Google Scholar 

  • Dreier B, Hammad-Zulfoghari D, Beiteke U et al. (1997) Papulöse Muzinose — erfolgreiche Behandlung mit Plasmapherese. Hautarzt 48: 648–652

    Article  PubMed  CAS  Google Scholar 

  • Egan CA, Grant WJ, Morris SE et al. (1999) Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol 40:458–461

    Article  PubMed  CAS  Google Scholar 

  • Egan CA, Meadows KP, Zone JJ (2000) Plasmapheresis as a steroid saving procedure in bullous pemphigoid. Int J Dermatol 39:230–235

    Article  PubMed  CAS  Google Scholar 

  • Frey BM, Fopp M (1993): Therapeutische Plasmapherese — eine kritische Würdigung unter Berücksichtigung der aktuellen Literatur. Schw Med Wschr 123: 1725–1735

    CAS  Google Scholar 

  • Graf N, Bambauer R, Jost W, Schafer M (1990) Der Stellenwert der Plasmapherese und des Cyclosporin A in der Behandlung des systemischen Lupus erythematodes. Monatsschr Kinderheilkd 138:395–398

    PubMed  CAS  Google Scholar 

  • Greaves M (2000) Chronic urticaria. J Allergy Clin Immunol 105: 664–672

    Article  PubMed  CAS  Google Scholar 

  • Hashimoto H, Yano T, Kawanishi T et al. (1999) Outcome of collagen vascular diseases by treatment with plasmapheresis. Ther Apher 2:268–272

    Article  Google Scholar 

  • Ivanovich P, Schmitt E, Klinkmann H (1988) Plasmapherese — eine internationale Standortbestimmung. Z Gesamt Inn Med 43:693–696

    CAS  Google Scholar 

  • Kaminska R, Ikaheimo R, Hollmen A (1999) Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum. Clin Exp Dermatol 24: 81–85

    Article  PubMed  CAS  Google Scholar 

  • Medenica R, Lasovic G, Long P et al. (1997) Plasmapheresis combined with somatostatin is a successful treatment of porphyrias. Ther Apher 1:159–164

    Article  PubMed  CAS  Google Scholar 

  • Mokrzycki MH, Kaplan AA (1994) Therapeutic plasma exchange: complications and management. Am J Kidney Dis 23: 817–827

    PubMed  CAS  Google Scholar 

  • Ogata K, Yasuda K, Matsushita M et al. (1999) Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method. J Dermatol 26:236–239

    PubMed  CAS  Google Scholar 

  • Shapiro M, Jimenez S, Werth VP (2000) Pemphigus vulgaris induced by D-penicillamine in a patient with systemic sklerosis. J Am Acad Dermatol 42: 297–299

    Article  PubMed  CAS  Google Scholar 

  • Stebler C, Tichelli A, Dazzi H et al. (1991) Immunglobulinmangel nach wiederholter Plasmapherese. Schw Med Wschr 121:145–149

    CAS  Google Scholar 

  • Steinhoff J, Schulz E, Herbst EW et al. (1988) Therapie der Amyloidnephrose bei Morbus Crohn: Plasmapherese plus Azathioprin? Wien Med Wschr 138: 49–54

    PubMed  CAS  Google Scholar 

  • Tashimoto Y, Suga Y, Yoshiike T et al. (2000) A case of antiepiligrin cicatricial pemphigoid successfully treated by plasmapheresis. Dermatology 201:58–60

    Article  Google Scholar 

  • Turner MS, Sutton D, Sauder DN (2000) The use of plasmapheresis annd immunesuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol 43:1058–1064

    Article  PubMed  CAS  Google Scholar 

  • Waxenberger Y, Schad S, Gross D et al. (1992): Rheologische Untersuchungen vor und nach therapeutischen Zytapheresen und Plasmaaustauschbehandlungen. Beitr Infusionsth 30:301–305

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Benjamin Franklin Freie Universität Berlin, Fabeckstr. 60-62, 14195, Berlin, Deutschland

    Prof. Dr. Prof. h. c. Constantin E. Orfanos

  2. Hautklinik und Poliklinik, Eberhard-Karls-Universität, Liebermeisterstr. 25, 72076, Tübingen, Deutschland

    Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h. c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

U. Blume-Peytavi C. C. Geilen S. Goerdt H. Gollnick E. Haneke F.-M. Köhn B. Tebbe R. Treudler Ch. C. Zouboulis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (2002). Bullöse Dermatosen. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56219-8_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62541-1

  • Online ISBN: 978-3-642-56219-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation